Industry news

Lead Story

FDA AEMS image

FDA launches new consolidated adverse event reporting system

2026-03-16T16:54:00+00:00By

The US Food and Drug Administration has introduced a consolidated adverse event database spanning all regulated product categories, from medical products and devices to food, cosmetics and veterinary medicines, aiming to enhance cross-category safety surveillance.

Industry news

FDA_Ultra rare diseases image

FDA launches framework for accelerating development of individualised therapies for ultra-rare diseases

2026-02-26T15:22:00+00:00By

This industry news explores new FDA draft guidance that considers the use of the plausible mechanism framework to develop individualised medicines where randomised controlled trials are not feasible.

CE mark image

MHRA seeks views on indefinite acceptance of CE-marked medical devices

2026-02-25T14:20:00+00:00By

This industry news update summarises the MHRA proposals for indefinite recognition of CE-marked medical devices in Great Britain and the potential impact for health systems and patients.

ICH M15 image

New ICH M15 Guideline sets harmonised framework for MIDD

2026-02-18T11:04:00+00:00By

This industry news update gives details of the ICH M15 adoption and its aim to establish standardised good practice for the use of evidence derived from model-informed drug development.

FDA approval image

FDA approves non-invasive device for pancreatic cancer treatment

2026-02-13T11:22:00+00:00By

This industry news update shares details of the FDA’s approval of Optune Pax, a medical device enabling treatment in a home setting.

DIN SPEC 91509_image

DIN SPEC 91509: A milestone for structured, digital medical device documentation

2026-01-30T12:29:00+00:00By

This industry news update introduces a new model that will help with the digitalisation of documentation under EU law.

MHRA clinical trials image 1

MHRA points to clinical trial growth and faster assessment routes

2026-01-28T09:44:00+00:00By

This industry news update shares how clinical trials have grown over the past year and new regulations coming into effect.